Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Cancer

NCT00003732 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: carboplatin
DRUG: paclitaxel
DRUG: topotecan hydrochloride

Sponsor

Rigshospitalet, Denmark